|
Miltenyi Biotec
α human hla dr microbeads ![]() α Human Hla Dr Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pmc06250054-101-0-4?v=Miltenyi+Biotec Average 93 stars, based on 1 article reviews
α human hla dr microbeads - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
hladr ![]() Hladr, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pmc12681927-314-43-48?v=Miltenyi+Biotec Average 95 stars, based on 1 article reviews
hladr - by Bioz Stars,
2026-07
95/100 stars
|
Buy from Supplier |
|
Diaclone
human leucocyte antigen hla class ii conjugated to phycoerythrin pe ![]() Human Leucocyte Antigen Hla Class Ii Conjugated To Phycoerythrin Pe, supplied by Diaclone, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pm12877680-91-21-59?v=Diaclone Average 85 stars, based on 1 article reviews
human leucocyte antigen hla class ii conjugated to phycoerythrin pe - by Bioz Stars,
2026-07
85/100 stars
|
Buy from Supplier |
|
R&D Systems
anti hla dr ![]() Anti Hla Dr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pm26773232-83-12-15?v=R%26D+Systems Average 93 stars, based on 1 article reviews
anti hla dr - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
dq antibodies ![]() Dq Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pm38092725-351-9-14?v=Miltenyi+Biotec Average 93 stars, based on 1 article reviews
dq antibodies - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
hla dr ![]() Hla Dr, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pm30127384-223-12-14?v=Miltenyi+Biotec Average 94 stars, based on 1 article reviews
hla dr - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Proteintech
hla dra ![]() Hla Dra, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pmc12983932-280-32-33?v=Proteintech Average 94 stars, based on 1 article reviews
hla dra - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
R&D Systems
hla dr pe ![]() Hla Dr Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pmc03318947-103-15-17?v=R%26D+Systems Average 94 stars, based on 1 article reviews
hla dr pe - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Novus Biologicals
hla dr ab ![]() Hla Dr Ab, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/ppr0870919-237-34-38?v=Novus+Biologicals Average 94 stars, based on 1 article reviews
hla dr ab - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Novus Biologicals
mouse anti hla dq dr dp ![]() Mouse Anti Hla Dq Dr Dp, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pm37903863-296-169-173?v=Novus+Biologicals Average 93 stars, based on 1 article reviews
mouse anti hla dq dr dp - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Bio-Rad
hla dr ![]() Hla Dr, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/pm28099414-486-20-27?v=Bio-Rad Average 93 stars, based on 1 article reviews
hla dr - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Bio X Cell
l243 ![]() L243, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hla+dr/us10286063-273-16-18?v=Bio+X+Cell Average 93 stars, based on 1 article reviews
l243 - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell host & microbe
Article Title: SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected resting memory CD4+ T cells
doi: 10.1016/j.chom.2018.09.007
Figure Lengend Snippet: KEY RESOURCES TABLE
Article Snippet:
Techniques: Virus, Recombinant, Marker, Enzyme-linked Immunosorbent Assay, Cell Isolation, shRNA, Transduction, Software
Journal: Molecular Therapy Oncology
Article Title: Near-infrared photoimmunotherapy for effective elimination of ovarian cancer cells by inducing immunogenic cell death
doi: 10.1016/j.omton.2025.201086
Figure Lengend Snippet: Co-culturing of NIR-PIT-treated ovarian cancer cells with iDCs promotes DC maturation (A) Schematic diagram of determining DC maturation experiments. (B) Immature DCs were cultured with scFv-Erbitux-SNAP-IR700-treated OVCAR4 cells or cultured with scFv-Erbitux-SNAP-treated OVCAR4 cells. (C) Immature DCs were cultured with scFv-Tisotumab-SNAP-IR700-treated SKOV3 cells or cultured with scFv-Tisotumab-SNAP-treated SKOV3 cells. After 48 h, the expressions of CD80, CD86, CD40, and HLADR on DCs were analyzed by flow cytometry. Immature DCs without co-culture are shown as a control. The expressions of CD80, CD86, HLADR, and CD40 on DCs are presented as flow cytometric histograms. The gray curves represent iDCs without co-culture. MFI of CD80, CD86, HLADR, and CD40 expression on DCs are shown in the bar graph. Graphs with error bars indicate mean ± SD from 3 biological replicates. Statistical significance was determined using unpaired t test. ∗ p ≤ 0.05, ∗∗∗ p ≤ 0.001, ∗∗∗∗ p ≤ 0.0001.
Article Snippet: Cells were incubated with 1.0 μg of CD80 (APC conjugated, clone B7-1, Invitrogen #17-0809-42) antibody and 2 μL of CD86 (PE conjugated, clone FM9-5, Miltenyi Biotec #130-094-877) antibody, 1.0 μg of CD40 (FITC conjugated, clone MH40-3, Invitrogen #11-0402-82) antibody, and 2 μL of
Techniques: Cell Culture, Flow Cytometry, Co-Culture Assay, Control, Expressing
Journal: Journal for Immunotherapy of Cancer
Article Title: Dual regulation of CXCR6+CD8+ T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression
doi: 10.1136/jitc-2025-014276
Figure Lengend Snippet: M1-like macrophages secrete CXCL16 and support CXCR6 + CD8 + T-cell recruitment but are progressively lost during PCa progression. ( A ) UMAP plot of tumor-infiltrating myeloid cells from PCa tissues, identifying five distinct clusters, including an IL1B + macrophage subset. ( B ) Dot plot showing average expression and detection frequency of selected marker genes across macrophage and dendritic cell (DC) clusters. ( C ) Violin plots illustrating the expression of key pro-inflammatory ( IL1B , TLR2 , CD86 ), anti-inflammatory ( CD163 , MRC1 ), and chemokine ( CXCL16 ) genes across myeloid subsets. ( D ) AUCell-based quantification of M1 and M2 gene signatures across clusters; IL1B + macrophages exhibit the highest M1 signature score. Kruskal-Wallis test, ****p<0.0001. ( E ) CellChat network visualizing outgoing macrophage-derived signals to CD8 + T-cell subsets; IL1B + macrophages prominently interact with CXCR6 + TEff-like CD8 + T cells. ( F ) Bubble plot visualizing the results of ligand–receptor interaction analysis; CXCL16–CXCR6 axis ranks among the strongest predicted signals. ( G ) Gating strategy for the identification of murine bone marrow-derived macrophages (BMDMs) induced with M-CSF. ( H ) Flow cytometry of BMDMs polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by CD80 and CD206 expression. ( I ) Confocal images of THP-1-derived macrophages stained for CD68 after PMA induction. ( J ) Flow cytometry of THP-1-derived macrophages polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by MHC-II and CD206 expression. ( K ) Immunoblots showing higher CXCL16 levels in M1-polarized BMDMs compared with their M2 counterparts. ( L ) ELISA quantification of secreted CXCL16 in the supernatants of M1-polarized and M2-polarized THP-1-derived macrophages. Mann-Whitney U test, **p<0.01. ( M ) Immunoblot analysis demonstrating elevated levels of CXCL16 in M1-polarized THP-1-derived macrophages compared with M2-polarized cells. (N, O). A total of 5×10⁶ TRAMP-C1 cells suspended in 100 µL PBS were subcutaneously implanted into the right flank of 5–6-week-old male WT C57BL/6J mice (n=5 per group). Tumors were harvested at day 35 (early stage) and day 49 (advanced stage) post-inoculation. Flow cytometric analysis of TAMs revealed a significant reduction in the ratio of MHCII + CD206⁻ (M1-like) to MHCII⁻ CD206 + (M2-like) macrophages during tumor progression. Mann-Whitney U test, **p<0.01. ( P ) Multiplex immunohistochemistry of human PCa tissues (GS=3+4 vs GS=5+5) demonstrated spatial proximity between CXCL16 + M1-like macrophages (HLA-DRA + ) and CXCR6 + CD8 + T cells in lower-grade (GS=3+4) tumors, which was largely diminished in high-grade (GS=5+5) lesions. Black arrows indicate matched regions across serial tissue sections. Scale bars: upper panels, 100 µm; lower panels, 40 µm. AUCell, area under the recovery curve; GS, Gleason Score; M-CSF, macrophage colony-stimulating factor; PCa, prostate cancer; PBS, phosphate-buffered saline; TAMs, tumor-associated macrophages.
Article Snippet: Sections were then incubated overnight at 4°C with primary antibodies against CD8 (Abcam, ab17147; 1:200), CXCR6 (Abcam, ab8023; 1:100), CXCL16 (ProteinTech Group, 60123-1-Ig; 1:100), CD68 (Abcam, ab125212; 1:200), iNOS (Abcam, ab3523; 1:200),
Techniques: Expressing, Marker, Derivative Assay, Flow Cytometry, Staining, Western Blot, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY, Multiplex Assay, Immunohistochemistry, Saline
Journal: Journal for Immunotherapy of Cancer
Article Title: Dual regulation of CXCR6+CD8+ T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression
doi: 10.1136/jitc-2025-014276
Figure Lengend Snippet: IL-10–STAT3–FOXO1 signaling reprograms CXCR6 + CD8 + T cells toward a dysfunctional state. ( A ) Dot plot showing the expression of IL10RA , STAT3 , STAT4 , CXCR6 , and related markers across CD8 + T cell subsets in scRNA-seq data. ( B ) IL-10 pathway activity scores across CD8 + T cell clusters. Kruskal-Wallis test, ****p<0.0001. (C, D) Murine splenic CD8 + T cells cultured in a medium containing anti-CD3 (5 µg/mL), anti-CD28 (5 µg/mL), and IL-2 (10 ng/mL) for 48 hours. Following initial activation, cells were maintained in fresh medium supplemented with IL-2 (10 ng/mL) for an additional 7 days. On day 9, cells were treated with 20 ng/mL murine IL-10, IL-15, or STAT3 inhibitor Stattic (2 µM) for 24 hours. The protein expression of STAT3, p-STATS, FOXO1, KLF2, and CXCR6 was assessed by Western blot analysis. (E, F) Flow cytometry of mouse spleen-derived CD8 + T cells shows preferential expression of IL-10R on CXCR6 + CD8 + T cells, with upregulation observed following TCR stimulation (anti-CD3/CD28+IL-2, day 10), indicating heightened susceptibility to IL-10-mediated signaling. (G–I) Flow cytometry of human peripheral blood mononuclear cell (PBMC) CD8 + T cells from healthy donors similarly demonstrates enhanced IL-10R expression on CXCR6 + CD8 + T cells and its induction on TCR stimulation. ( J ) PCA of bulk RNA-seq. Prostate tissues from Pb-Cre; Pten flox/flox ( T ) and WT mice (n=3/group) were profiled by bulk RNA-seq. PCA separated T (blue) from WT (red) chiefly along PC1 (87.24% variance) and PC2 (5.64%). ( K ) Sample-to-sample distance heatmap. Distance matrix based on transformed expression values shows tight clustering of biological replicates within genotype and clear segregation between T and WT. ( L ) Volcano plot. Differential expression analysis between T and WT (cut-offs |log2FC|≥1.5, FDR<0.05). Points are colored by direction (Up=red; Down=blue). Dashed lines indicate thresholds. Il10 , Mrc1 , Cd163 , and Cxcr6 are highlighted in purple; other selected genes are labeled as indicated. Y-axis shows –log 10 (adjusted p). ( M ) Multiplex immunofluorescence (human prostate). Representative fields from human prostate specimens (n=9). Channels: DAPI (nuclei), CD68 (pan-macrophage), HLA-DRA (M1-like macrophage), CD163 (M2-like macrophage), and IL-10. IL-10 signal is enriched in tumor regions and co-localizes with CD68 + CD163 + macrophages. Scale bar: 20 µm. DAPI, 4′,6-diamidino-2-phenylindole; FDR, false discovery rate; PCA, principal component analysis; scRNA-seq, single-cell RNA sequencing; WT, wild-type.
Article Snippet: Sections were then incubated overnight at 4°C with primary antibodies against CD8 (Abcam, ab17147; 1:200), CXCR6 (Abcam, ab8023; 1:100), CXCL16 (ProteinTech Group, 60123-1-Ig; 1:100), CD68 (Abcam, ab125212; 1:200), iNOS (Abcam, ab3523; 1:200),
Techniques: Expressing, Activity Assay, Cell Culture, Activation Assay, Western Blot, Flow Cytometry, Derivative Assay, RNA Sequencing, Transformation Assay, Quantitative Proteomics, Labeling, Multiplex Assay, Immunofluorescence, Single Cell